3.78 0.00 (0.00%)
After hours: 4:26PM EDT
|Bid||3.77 x 21500|
|Ask||3.84 x 1200|
|Day's Range||3.71 - 3.92|
|52 Week Range||3.20 - 6.15|
|Beta (3Y Monthly)||2.95|
|PE Ratio (TTM)||N/A|
|Earnings Date||Oct 30, 2018|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||6.70|
The big shareholder groups in Accuray Incorporated (NASDAQ:ARAY) have power over the company. Insiders often own a large chunk of younger, smaller, companies while huge companies tend to have institutions Read More...
NEW YORK, NY / ACCESSWIRE / September 28, 2018 / U.S. markets finished higher on Thursday as the jobless claims increase was smaller than expected and second quarter GDP rose 3.1%, marking the best growth ...
How far off is Accuray Incorporated (NASDAQ:ARAY) from its intrinsic value? Using the most recent financial data, I am going to take a look at whether the stock is fairlyRead More...
NEW YORK, Aug. 28, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Scientific ...
In August, nine analysts are covering Varian Medical Systems (VAR) stock. Three of them have given the stock a “strong buy” rating, three have given it a “hold,” and three have given it a “sell.” The mean rating for VAR stock is 2.67 with a target price of $122. That implies an upside potential of 9.1% over its closing price of $111.83 on August 20.
NEW YORK, NY / ACCESSWIRE / August 16, 2018 / Accuray Incorporated (NASDAQ: ARAY ) will be discussing their earnings results in their Q4 Earnings Call to be held on August 16, 2018 at 4:30 PM Eastern Time. ...
Stock Research Monitor: WMGI, ZBH, and ARAY LONDON, UK / ACCESSWIRE / July 17, 2018 / If you want a free Stock Review on VRAY sign up now at www.wallstequities.com/registration . Pre-market today, WallStEquities.com ...
The Atomic Energy Regulatory Board (AERB) approves Accuray's (ARAY) Radixact X9 in India; exposes the company to AI and Mechatronic trends.
Accuray Incorporated (NASDAQ:ARAY), a medical equipment company based in United States, received a lot of attention from a substantial price movement on the NasdaqGS over the last few months, increasingRead More...
This Monday, WallStEquities.com has initiated reports coverage on the following Medical Appliances & Equipment equities: Neovasc Inc. (NASDAQ: NVCN), Smith & Nephew PLC (NYSE: SNN), Accuray Inc. (NASDAQ: ARAY), and AcelRx Pharmaceuticals Inc. (NASDAQ: ACRX). All you have to do is sign up today for this free limited time offer by clicking the link below.
Regulatory issues regarding Onrad, intense competition in the radiation oncology market and unfavorable foreign exchange rate are significant challenges for Accuray (ARAY).
Accuray (ARAY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
This Wednesday, WallStEquities.com has initiated reports coverage on the following Medical Appliances & Equipment equities: Accuray Inc. (NASDAQ: ARAY), AcelRx Pharmaceuticals Inc. (NASDAQ: ACRX), and CHF Solutions Inc All you have to do is sign up today for this free limited time offer by clicking the link below. Sunnyvale, California headquartered Accuray Inc.'s stock finished Tuesday's session 3.23% lower at $4.50 with a total trading volume of 429,142 shares.